Patents Assigned to Aventis Pharma AG
  • Publication number: 20040102518
    Abstract: The invention relates to N-benzoylureidocinnamic acid derivatives and to their physiologically tolerated salts and physiologically functional derivatives.
    Type: Application
    Filed: June 6, 2003
    Publication date: May 27, 2004
    Applicant: Aventis Pharma AG
    Inventors: Karl Schoenafinger, Elisabeth Defossa, Dieter Kadereit, Erich Von Roedern, Thomas Klabunde, Hans-Joerg Burger, Andreas Herling, Karl-Ulrich Wendt